4.6 Article

Twenty-Four-Month Blood Pressure Results After Renal Denervation Using Endovascular Ultrasound

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Cardiac & Cardiovascular Systems

6-and 12-Month Follow-Up From a Randomized Clinical Trial of Ultrasound vs Radiofrequency Renal Denervation (RADIOSOUND-HTN)

Karl Fengler et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2023)

Article Cardiac & Cardiovascular Systems

Clinical event reductions in high-risk patients after renal denervation projected from the global SYMPLICITY registry

Roland E. Schmieder et al.

Summary: Renal denervation using radiofrequency has been found to lower blood pressure and reduce cardiovascular events in patients with uncontrolled hypertension. The magnitude of blood pressure reduction and associated risks of cardiovascular events vary among different high-risk subgroups. Model-based projections suggest that radiofrequency renal denervation provides significant clinical benefits for patients with uncontrolled hypertension.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2023)

Article Medicine, General & Internal

Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial

Felix Mahfoud et al.

Summary: In this study, the long-term safety and efficacy of renal denervation were evaluated. The results showed that renal denervation produced a clinically meaningful and lasting blood pressure reduction up to 36 months, independent of concomitant antihypertensive medications and without major safety events.

LANCET (2022)

Article Medicine, General & Internal

Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial

Deepak L. Bhatt et al.

Summary: The 36-month follow-up of the SYMPLICITY HTN-3 trial demonstrates the long-term safety and efficacy of renal artery denervation in patients with treatment-resistant hypertension. Patients who received renal artery denervation showed significant reductions in blood pressure and better blood pressure control compared to those who received sham control.

LANCET (2022)

Article Cardiac & Cardiovascular Systems

Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial

Florian Rader et al.

Summary: This study assessed the long-term durability of ultrasound RDN in lowering blood pressure. The results showed that over a period of 36 months, patients experienced reduced blood pressure and improved blood pressure control, without any new long-term safety concerns.

EUROINTERVENTION (2022)

Article Cardiac & Cardiovascular Systems

Assessment of arterial stiffness to predict blood pressure response to renal sympathetic denervation

Karl Fengler et al.

Summary: This study aimed to assess the ability of invasive and non-invasive methods to predict the response of blood pressure to renal sympathetic denervation (RDN). The results showed that iPWV is an independent predictor for blood pressure response after RDN, and non-invasive methods can also predict blood pressure changes.

EUROINTERVENTION (2022)

Article Physiology

Contributions of afferent and sympathetic renal nerves to cystogenesis and arterial pressure regulation in a preclinical model of autosomal recessive polycystic kidney disease

Madeline M. Gauthier et al.

Summary: Polycystic kidney disease is the most common genetic cause of kidney failure. This study investigated the role of renal nerves in the development of cysts in a preclinical model of autosomal recessive PKD. The researchers found that increased afferent renal nerve activity was associated with greater cystogenesis in PKD rats.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Comparison of Long-Term Outcomes for Responders Versus Non-Responders Following Renal Denervation in Resistant Hypertension

Karl Fengler et al.

Summary: Observational data indicates that blood pressure response to renal sympathetic denervation is associated with improved long-term clinical outcomes. The study found that patients who responded to the treatment had significantly fewer major adverse cardiovascular events during a median follow-up period of 48 months compared to non-responders.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)

Article Medicine, General & Internal

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Michel Azizi et al.

Summary: Renal denervation through ultrasound treatment shows promising results in reducing blood pressure for patients with resistant hypertension, with greater effectiveness compared to a sham procedure within 2 months and similar safety outcomes. This may provide an alternative approach for patients with resistant hypertension to avoid adding more antihypertensive medications.

LANCET (2021)

Article Physiology

Responsiveness of afferent renal nerve units in renovascular hypertension in rats

Kristina Rodionova et al.

Summary: The study showed that renal afferent nerve activity is influenced by intrarenal inflammation, with a more pronounced effect on neurons with axons from the clipped kidneys. Furthermore, the electrophysiological properties of neurons may play a role in the increased sympathetic activity observed in hypertension.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Renal arteries denervation with second generation systems: a remedy for resistant hypertension?

Francesco Versaci et al.

EUROPEAN HEART JOURNAL SUPPLEMENTS (2020)

Review Cardiac & Cardiovascular Systems

2018 ESC/ESH Guidelines for the management of arterial hypertension

Bryan Williams et al.

EUROPEAN HEART JOURNAL (2018)

Article Physiology

Complex reinnervation pattern after unilateral renal denervation in rats

Kristina Rodionova et al.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2016)

Review Cardiac & Cardiovascular Systems

Renal Denervation for Hypertension

Stefan C. Bertog et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2012)